SCHEMBL29253769

SCHEMBL29253769

C[C@H](OC(=O)NC(C)(C)C)C(=O)NCc1ccccc1F

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.50
▸ SLC1A2 P43004 1/20 0.50
▸ TACR1 P25103 1/20 0.43
▸ TACR3 P29371 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ CTSS P25774 1/20 0.42
▸ CTSK P43235 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PKM P14618 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29253671 1.00 RIPK1 (0.50) RIPK1SLC1A2TACR1TACR3POLB
SCHEMBL29253680 0.82 SLC1A2 (0.54) RIPK1SLC1A2POLBHPGDALDH1A1
SCHEMBL29253631 0.82 KMT2A (0.56) SLC1A2HPGDTSHRKMT2A
SCHEMBL29253670 0.82 KMT2A (0.56) SLC1A2HPGDTSHRKMT2A
SCHEMBL29253705 0.82 SLC1A2 (0.54) RIPK1SLC1A2POLBHPGDALDH1A1
SCHEMBL29253682 0.82 SLC1A2 (0.54) RIPK1SLC1A2POLBHPGDALDH1A1
SCHEMBL2905073 0.78 SLC1A2 (0.65) RIPK1SLC1A2HPGDALDH1A1MAPT
SCHEMBL10172968 0.77 RIPK1 (0.61) RIPK1SLC1A2HTTHPGDALDH1A1
SCHEMBL30968603 0.75 CTSS (0.57) RIPK1SLC1A2CTSSCTSKKMT2A
SCHEMBL30968604 0.75 CTSS (0.57) RIPK1SLC1A2CTSSCTSKKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302410-A Deuterated functionalized derivatives of alpha-alanine, in particular for the treatment of neurological diseases 雅盖隆大学 2024-07-05 — — CN disclosed
Send feedback